New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

CVS Health Corporation

CVS

Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.

Revenue
+5.37%
EPS
n/m
Free cash flow
+3,886.7%
Total debt
−7.83%

Quarter to September 2026, against a year earlier

80.05 1.30 −1.60%

After hours trading: 80.05, unchanged, last trade Thu 7:55pm Eastern.

Market cap
$104.1B
P/E
9.2×
Fwd P/E FY26e
12.8×
Dividend yield
3.32%
F-score
7/9
ROIC
7.44%
Net debt / EBITDA
3.6×
Payout ratio
0.3×

Revenue to profit Q3 FY2026, quarter to 30 September 2026

Of every $100 of revenue, $2.00 was left as profit. Gross margin has fallen two quarters running, from 44.8% to 43.6%. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue108.4100.0%
Cost of revenue−61.2−56.4%
Gross profit47.243.6%
Other operating costs−43.6−40.3%
Operating income3.63.3%
Other income, net−0.7−0.7%
Income tax−0.7−0.6%
Net income2.22.0%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$105.7B$100.4B$106.1B$108.4B
Operating income$2.1B$4.7B$4.7B$3.6B
Net income$2.9B$3.0B$3.0B$2.2B
Net margin (right axis)2.8%2.9%2.8%2.0%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
108,399.00 106,096.00 100,426.00 105,693.00

+8 more quarters

Revenue Growth
5.37% 7.26% 6.17% 8.17%
Gross Profit
47,214.00 47,234.00 44,982.00 46,633.00
Operating Income
3,566.00 4,703.00 4,680.00 2,112.00
EBT
2,849.00 3,977.00 3,938.00 1,354.00
Income after Tax
2,171.00 2,995.00 2,957.00 2,923.00
Net Income Common
2,172.00 2,979.00 2,943.00 2,943.00
EPS (Diluted)
1.68 2.31 2.30 2.30
Shares (Diluted, Weighted)
1,291.00 1,287.00 1,279.00 1,271.00
Gross Margin
43.56% 44.52% 44.79% 44.12%
EBIT Margin
3.29% 4.43% 4.66% 2.00%
Net Profit Margin
2.00% 2.81% 2.93% 2.78%
EBITDA
4,698.00 5,829.00 5,795.00 3,259.00
EBIT
3,566.00 4,703.00 4,680.00 2,112.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 18 Nov 2026